Flourish Research

COVID/FLU Vaccine

COVID/Flu Vaccine

To qualify for the COVID/Flu study you must:

Basic Criteria: 

  • Be ages 18-64
  • If you have had a previous COVID-19 vaccine, has it been at least 6 months? 
    • If yes, are you able to bring a vaccination card or know the month and year? 
  • If you have had a previous flu vaccine, has it been at least 6 months? 
    • If yes, are you able to bring the month and year? 

Answers Must Be No: 

  • Are you nursing or pregnant? 
  • Have you ever had a severe adverse reaction to a vaccine or any severe allergic reaction? 
  • Are you immunocompromised? 
  • Do you have a bleeding disorder that would be affected by an intramuscular injection? 
  • Do you have HIV? Treated/stable meds with medical records OK 
  • Do you have a history of Hepatitis B or C? Treated/stable meds with medical records OK 
  • Have you received blood or blood products, immunoglobulin or monoclonal antibodies in the past 60 days? 
  • Have you received any immunosuppressive medications (such as corticosteroids for cancer or autoimmune disease) or radiotherapy in the past 60 days? 
  • Have you been in another study in the past 28 days? 

Answers Must Be Yes 

  • Are you able to read and sign consent? 
  • Do you have one arm free or dermatological conditions (tattoos, psoriasis) in the upper arm? 
  • If you have any chronic conditions are you stable for past 6 weeks (no changes in meds or hospitalizations)? 
  • If female of child-bearing potential do you agree to use contraception for at least 28 after receiving study vaccine? 
    • The following forms of contraception are acceptable:
        • Implantable progestogen-only hormone contraception associated with inhibition of ovulation. 
        • Intrauterine device. 
        • Intrauterine hormone-releasing system. 
        • Bilateral tubal occlusion. 
        • Vasectomized partner: 
        • Combined (estrogen and progestogen-containing) hormonal contraception associated with inhibition of ovulation: 
        • Oral; 
        • Intravaginal; 
        • Transdermal. 
        • Progestogen-only hormone contraception associated with inhibition of ovulation: 
        • Oral; 
        • Injectable. 
        • Sexual abstinence 
        • Progestogen-only oral hormonal contraception where inhibition of ovulation is not the primary mode of action. 
        • Male or female condom, with or without spermicide. 
        • Cervical cap, diaphragm, or sponge with spermicide. 
        • A combination of male condom with either cervical cap, diaphragm, or sponge with spermicide (double-barrier methods). 
  • Women of non-childbearing potential: Hysterectomy, bilateral salpingectomy, bilateral oophorectomy, 12 months post-menopausal 
  • If male with a partner of child-bearing potential, do you agree to refrain from donating sperm while in the study and if not vasectomized agree to use a male condom, and should also be advised of the benefit for a female partner to use a highly effective method of contraception 
  • Additional criteria will apply   

 

Compensation up to $650 is available for time and travel.

 PLEASE NOTE: Please confirm your eligibility before your appointment by calling 210-714-0067

 

If you do not see an available appointment, please call 210-714-0067 for availability 

 

Transportation may be available. Call 210-714-0067

Schedule Appointment
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.